SCHEMBL24320669

SCHEMBL24320669

COC(C)(O)c1ccc(Cl)cc1F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 6/20 0.41
CYP3A5 P20815 5/20 0.41
HDAC3 O15379 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC2 Q92769 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
HTT P42858 1/20 0.36
ALDH1A1 P00352 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
CASR P41180 2/20 0.35
NR3C1 P04150 5/20 0.34
NR3C2 P08235 3/20 0.34
PGR P06401 1/20 0.34
TSHR P16473 1/20 0.34
MAPK1 P28482 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
CYP11B1 P15538 1/20 0.34
CYP11B2 P19099 1/20 0.34
CYP19A1 P11511 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31159673 0.81 HDAC3 (0.39) CYP3A4CYP3A5HDAC3HDAC1HDAC2
SCHEMBL22009767 0.81 HDAC3 (0.39) CYP3A4CYP3A5HDAC3HDAC1HDAC2
SCHEMBL22544183 0.81 CYP3A4 (0.45) CYP3A4CYP3A5HDAC3HDAC1HDAC2
SCHEMBL17186902 0.81 CYP3A4 (0.45) CYP3A4CYP3A5HDAC3HDAC1HDAC2
SCHEMBL30217501 0.79 CYP3A4 (0.40) CYP3A4CYP3A5HDAC3HDAC1HDAC2
SCHEMBL1690351 0.77 HDAC3 (0.42) CYP3A4CYP3A5HDAC3HDAC1HDAC2
SCHEMBL29924192 0.75 CYP3A4 (0.41) CYP3A4CYP3A5HDAC3HDAC1HDAC2
SCHEMBL1627738 0.75 HDAC3 (0.46) CYP3A4CYP3A5HDAC3HDAC1HDAC2
SCHEMBL19304122 0.73 HDAC3 (0.40) CYP3A4CYP3A5HDAC3HDAC1HDAC2
SCHEMBL2795577 0.73 HDAC3 (0.40) CYP3A4CYP3A5HDAC3HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022078407-A1 HETEROCYCLIC GLP-1 AGONISTS GASHERBRUM BIO, INC. (US) 2022-04-21 WO disclosed